Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,296,200 | 4,589,190 | 5,970,460 | 11,865,700 | 8,830,920 |
| Marketable Securities | 6,872,140 | 5,188,110 | 6,747,900 | 3,463,910 | 4,083,240 |
| Receivables | 4,816,040 | 4,011,660 | 4,038,560 | 5,444,210 | 5,250,840 |
| Inventories | 4,710,700 | 4,619,550 | 4,502,960 | 6,408,600 | 6,179,880 |
| Other current assets | 7,321,560 | 2,259,060 | 2,249,080 | 2,037,470 | 1,983,240 |
| TOTAL | $28,016,640 | $20,667,570 | $23,508,960 | $29,219,890 | $26,328,120 |
| Non-Current Assets | |||||
| PPE Net | 7,979,540 | 7,846,680 | 7,973,230 | 12,900,930 | 12,990,600 |
| Investments And Advances | 5,412,490 | 4,565,730 | 2,359,840 | 3,417,220 | 2,852,640 |
| Other Non-Current Assets | 3,411,780 | 5,715,270 | 1,815,630 | 2,347,380 | 574,560 |
| TOTAL | $16,803,810 | $18,127,680 | $12,148,700 | $18,665,530 | $16,417,800 |
| Total Assets | $44,820,460 | $38,795,250 | $35,657,660 | $47,885,420 | $42,745,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,910,490 | 10,343,100 | 11,734,520 | 15,135,610 | 11,896,080 |
| TOTAL | $11,910,490 | $10,343,100 | $11,734,520 | $15,135,610 | $11,896,080 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,671,690 | 1,958,910 | 2,484,360 | 4,503,970 | 4,694,760 |
| Other Non-Current Liabilities | 3,137,500 | 2,872,470 | 2,972,840 | 4,826,771 | 3,753,960 |
| TOTAL | $7,303,050 | $6,788,910 | $5,484,030 | $9,296,131 | $9,408,000 |
| Total Liabilities | $19,213,560 | $17,132,010 | $17,218,570 | $24,431,750 | $21,304,080 |
| Shareholders' Equity | |||||
| Common Shares | 1,138,170 | 995,670 | 992,780 | 1,161,610 | 1,178,520 |
| Other shareholders' equity | 24,557,730 | 20,746,570 | 17,496,300 | 22,345,060 | 20,318,320 |
| TOTAL | $25,606,900 | $21,663,240 | $18,439,080 | $23,453,670 | $21,441,840 |
| Total Liabilities And Equity | $44,820,460 | $38,795,250 | $35,657,650 | $47,885,420 | $42,745,920 |